Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

DBV Technologies S.A.

Biological Products, (No Diagnostic Substances) · Chatillon

  1. PrincipalsDaniel TasseCHIEF EXECUTIVE OFFICERKevin Michael TrappChief Commercial OfficerPharis MohideenChief Medical Officerand 3 more
  2. CompanyDBV Technologies S.A.Chatillon
Request a quotedbv-technologies.com ↗

DBV Technologies S.A. is an SEC-registered Nasdaq-listed company (ticker DBVT) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 6

Chief executive

Daniel TasseCHIEF EXECUTIVE OFFICER

Chair & board

Felix BakerDirector (Board)
Julian BakerDirector (Board)

Finance

Virginie BoucinhaChief Financial Officer

Sales & commercial

Kevin Michael TrappChief Commercial Officer
Everyone else on file (1)
Pharis MohideenChief Medical Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Pharis Mohideen — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Daniel Tasse — CHIEF EXECUTIVE OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Kevin Michael Trapp — Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Virginie Boucinha — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers